ライフサイエンスコーパス: lower extremity

1 distal (tibial nerve) nerve segments of the lower extremity.

2 ately lead to amputation of a portion of the lower extremity.

3 uals with plaster cast immobilization of the lower extremity.

4 ntion and 12 (22%) underwent amputation of a lower extremity.

5 subcutaneous metastatic disease of the left lower extremity.

6 ion and minimal chronic swelling of the left lower extremity.

7 ately lead to amputation of a portion of the lower extremity.

8 distributed into 8 sites within the ischemic lower extremity.

9 shown to have somatosensory deficits of the lower extremity.

10 PT) using a biothesiometer at 5 sites at the lower extremity.

11 atients (9-18 years) with CRPS affecting the lower extremity.

12 d from the upper and lower back and from the lower extremity.

13 is during plaster cast immobilization of the lower extremity.

14 he extremities, including the weight-bearing lower extremities.

15 involuntary movements of the right upper and lower extremities.

16 of progressive paralysis of the upper and/or lower extremities.

17 computed tomographic (CT) angiography of the lower extremities.

18 de, resulting in increased blood flow to the lower extremities.

19 order affecting motor neuron function in the lower extremities.

20 part of the body, with predominance for the lower extremities.

21 multiple vascular territories including the lower extremities.

22 ) for the pelvis and 0.6 mSv +/- 0.2 for the lower extremities.

23 r, and multislice computed tomography of the lower extremities.

24 ally understudied topic, particularly in the lower extremities.

25 , and confluent plaques predominantly on the lower extremities.

26 n lesions that covered places other than the lower extremities.

27 ts that evaluated deficits in both upper and lower extremities.

28 rosis that results in ischemia mostly in the lower extremities.

29 in the major conduit arteries supplying the lower extremities.

30 annularis telangiectodes of Majocchi on the lower extremities 2 months after initiating isotretinoin

31 imaging and was classified as carotid (53%), lower extremity (41%), upper extremity (3%), and aortic

32 SEEs more frequently involved the lower extremity (58%) than visceral-mesenteric (31%) or

33 The most frequently injured site was the lower extremity (70.2%), and 47.9% of all injuries were

34 iption factor in a family with a spectrum of lower extremity abnormalities, including clubfoot.

35 bjects with knee OA to determine whether the lower extremity afferent deficits observed in knee OA in

36 sment of global spinal balance together with lower extremity alignment should be strongly recommended

37 reported, especially sensory symptoms in the lower extremities among those treated with oxaliplatin.

38 proximately 2-fold higher risk of below-knee lower extremity amputation (0.17 versus 0.09 events per

39 HR, 0.80 [95% CI, 0.46-1.38, P = .42]), and lower extremity amputation (3 vs 25; 1.9 vs 3.3/1000 per

40 occurring in southern Afghanistan (94%) with lower extremity amputation (80%) and large volume blood

41 ective abdominal aortic aneurysm repair, and lower extremity amputation from 1999 to 2004 (n = 563,84

42 ed all patients with CLI who underwent major lower extremity amputation in the 306 hospital referral

43 Despite mild reductions in rates of lower extremity amputation over the past decade, few dat

44 It remains unclear whether the below-knee lower extremity amputation risk extends across the class

45 ent peripheral arterial revascularization or lower extremity amputation, 4.6% died, and the median co

46 and related vascular care in the year before lower extremity amputation, across hospital referral reg

47 ascular events and higher risk of below-knee lower extremity amputation.

48 at AAA repair, incisional hernia repair, and lower extremity amputation.

49 exploratory safety end point was below-knee lower extremity amputation.

50 atistics System to compare the incidences of lower-extremity amputation, end-stage renal disease, acu

51 Over 60% of lower extremity amputations are performed in patients wi

52 ll, 20,464 patients with CLI underwent major lower extremity amputations during the study period, and

53 About 85% of lower extremity amputations in diabetes are attributed t

54 Lower extremity amputations were similarly increased in

55 betic foot infections are a leading cause of lower extremity amputations.

56 l to affect clinically relevant aspects of a lower extremity amputee's gait, it is currently unknown

57 /ED conversion coefficients are provided for lower extremities and allow estimation of ED for commonl

58 matic muscle hernias are not uncommon in the lower extremities and are a rare cause of chronic leg pa

59 yperkeratotic-affected skin on the upper and lower extremities and trunk, and identified a single, pr

60 ence of VTE after cast immobilization of the lower extremity and (2) to develop a clinical prediction

61 Five sites in the lower extremity and 1 site in the upper extremity (radia

62 s who had plaster cast immobilization of the lower extremity and that blood was drawn 3 mo after the

63 ambulatory status (McNemar test, P < .001), lower extremity and total motor scores (Wilcoxon signed

64 e deep and superficial venous systems of the lower extremities, and suggest the need for addition cli

65 re presented for evaluation of bowing of his lower extremities, and was ultimately diagnosed with X-l

66 effects on somatic symptoms, and upper body, lower extremity, and low back pain over six months.

67 nd ankle brachial index >/=1.4 who underwent lower extremity angiograms within 1 year were included.

68 Lower extremity angular deformities are among the most c

69 Limb length discrepancy and lower extremity angular deformity are among the most com

70 Inflammatory dermatoses of the lower extremity are often misdiagnosed as cellulitis (ak

71 Importance: Inflammatory dermatoses of the lower extremity are often misdiagnosed as cellulitis (ak

72 her a volume-outcome relationship exists for lower extremity arterial bypass (LEAB) surgery.

73 tients who underwent outpatient, noninvasive lower extremity arterial evaluation at the Mayo Clinic,

74 ified in the clinical setting by noninvasive lower extremity arterial evaluation.

75 A high ABI, a marker of lower extremity arterial stiffness, is associated with C

76 ry artery or renal artery revascularization, lower-extremity arterial disease, carotid endarterectomy

77 amputation rather than revascularization for lower-extremity arterial disease.

78 Epidemiology data for lower-extremity arterial thromboembolism (LET) are limit

79 future, it is hopeful that we will treat the lower extremity arteries according to segments, taking i

80 injury, and measured the attenuation in the lower extremity arteries.

81 fied nine persons with calcifications of the lower-extremity arteries and hand and foot joint capsule

82 Serial changes in lower extremity arteriogenesis and muscle perfusion were

83 help determine mechanisms of development of lower extremity atherosclerosis.

84 experienced immediate reduction in upper- to lower-extremity blood pressure difference with sustained

85 udy was to evaluate vascular function in the lower extremities by making direct time-course measureme

86 Lower extremity bypass grafting is most successful with

87 nal aortic aneurysm repair (51% vs 38%), and lower extremity bypass surgery (32% vs 3%).

88 mptomatic peripheral artery disease includes lower extremity bypass surgery (LEB) and peripheral endo

89 epair, abdominal aortic aneurysm repair, and lower extremity bypass surgery.

90 l quality for patients undergoing colectomy, lower extremity bypass, or all surgical procedures.

91 epair, abdominal aortic aneurysm repair, and lower extremity bypass.

92 ant patient with chronic skin lesions of the lower extremities caused by P. cyclothyrioides.

93 f a large urban hospital with a diagnosis of lower extremity cellulitis between June 2010 and Decembe

94 f a large urban hospital with a diagnosis of lower extremity cellulitis between June 2010 and Decembe

95 Misdiagnosis of lower extremity cellulitis is common and may lead to unn

96 Conclusions and Relevance: Misdiagnosis of lower extremity cellulitis is common and may lead to unn

97 ere admitted from the ED with a diagnosis of lower extremity cellulitis.

98 ulitis in patients admitted for treatment of lower extremity cellulitis.

99 ere admitted from the ED with a diagnosis of lower extremity cellulitis.

100 ulitis in patients admitted for treatment of lower extremity cellulitis.

101 decompressed and confirmed entry into all 4 lower extremity compartments.

102 h clinical outcome, and if available, repeat lower extremity CT angiographic, conventional angiograph

103 Integration of lower extremity CT angiography into multiphasic whole-bo

104 ard deviations were determined for the given lower-extremity CT examinations for all age groups and f

105 eart centers were prospectively assessed for lower extremity CVI, with the assignment of clinical, et

106 sorders exercised in a supine position, on a lower extremity cycle ergometer.

107 In patients with suspected lower extremity deep vein thrombosis (DVT), compression

108 Pediatric lower extremity deep vein thrombosis (LE-DVT) can lead t

109 rvention in the setting of acute and chronic lower extremity deep venous disease.

110 sis (CDT) in the treatment of acute proximal lower-extremity deep vein thrombosis is increasing in th

111 618 patients were hospitalized for proximal lower-extremity deep vein thrombosis, and 3649 patients

112 and hypertension, as well as more extensive lower extremity disease (all p values <0.05).

113 Ventilation-perfusion imaging and lower extremity Doppler ultrasonography were performed (

114 Lower extremity duplex studies showed 8 patients (6.7%)

115 Patients underwent a screening lower-extremity duplex ultrasound approximately 1 month

116 In a clinical study, 38 patients with lower extremity DVT or controls undergoing FDG-PET were

117 Common AEs (>/=20%) included fatigue, facial/lower extremity edema, nausea and vomiting, diarrhea, ge

118 Lower extremity edema, venous stenosis, right heart fail

119 subsided in a few months and transient, mild lower-extremity edema and muscle pain.

120 statins and longitudinal limb salvage after lower extremity endovascular revascularization and lower

121 o been a better mechanistic understanding of lower extremity endovascular treatment using tools such

122 issue bridges identified those patients with lower extremity evoked potentials and better clinical re

123 normal resting hemodynamics underwent supine lower extremity exercise testing.

124 ured during extremity vascular exposures and lower extremity fasciotomy in fresh cadavers before and

125 ence (r = 0.466, 95%CI: 0.432~0.500), except lower extremity fat (r = 0.088, 95%CI: -0.116~0.285).

126 s had less intraperitoneal (IP) fat and more lower extremity fat than their Hispanic and Caucasian co

127 subsequently recommended radiography of the lower extremities ( Fig 3 ).

128 e intervention >2 hrs (77% vs. 46%), complex lower extremity fracture (53% vs. 32%), and pelvic fract

129 These included stroke, lower extremity fracture, lower extremity joint replacem

130 edure, spinal cord paralysis, venous injury, lower extremity fracture, pelvic fracture, central line,

131 He has had two lower extremity fractures from falls at construction sit

132 us catheter placement, presence of pelvic or lower extremity fractures, and major surgery), and the p

133 re of fracture healing or weight bearing for lower extremity fractures.

134 tional limitations using validated measures: lower extremity function (Short Physical Performance Bat

135 iew yielded 115 clinical trials of upper and lower extremity function in chronic stroke that used a t

136 The mean baseline basic lower extremity function score was 78.2.

137 hanges in function on the basic and advanced lower extremity function subscales of the Late Life Func

138 d evidence to identify measures of upper and lower extremity function used to date as outcomes in tri

139 The mean changes in basic lower extremity function were 0.34 (95% CI, -0.84 to 1.5

140 cacy for arthritis management, and upper and lower extremity function.

141 ted health and psychosocial variables (e.g., lower-extremity function, body weight, rated stress) wer

142 in people with PAD: more severe PAD, greater lower extremity functional impairment, more adverse calf

143 were activity limitation assessed using the Lower Extremity Functional Scale (score range, 0-80; hig

144 lysis of serial targeted molecular images of lower extremities, has applicability to other targeted S

145 s that target all major muscle groups of the lower extremity have demonstrated superior long-term str

146 g musculoskeletal pain into lower back pain, lower extremity (hips, knees, and feet/ankles combined)

147 ity disability were attenuated in those with lower extremity impairment.

148 maging the deep and superficial veins of the lower extremities in a small cohort of healthy subjects

149 remity compartment syndrome of the upper and lower extremities in adults and children, discuss the un

150 ess was earlier onset and more severe in the lower extremities in nearly all patients.

151 beam CT scanner capable of imaging upper and lower extremities (including weight-bearing examinations

152 of the 55 incident cases (98%) of bilateral lower extremity inflammatory lymphedema occurred during

153 e 55 trainees (0.4%) who developed bilateral lower extremity inflammatory lymphedema that occurred du

154 ctors were ruled out as sources of bilateral lower extremity inflammatory lymphedema.

155 ducted for every confirmed case of bilateral lower extremity inflammatory lymphedema.

156 Patients in Boston sustained more lower extremity injuries because of the ground-level bom

157 patients who underwent CT angiography of the lower extremities integrated with multiphasic torso CT f

158 Lower extremity involvement in GCA and PMR may be associ

159 tic arterial occlusive disease affecting the lower extremities is also known as peripheral artery dis

160 ummary, impaired physical performance of the lower extremities is common in CKD and strongly associat

161 ients with the primary diagnosis of critical lower extremity ischemia from 2002-2008 were examined in

162 Lower extremity ischemia is also associated with pathoph

163 Among patients presenting with critical lower extremity ischemia, it has been previously documen

164 ritical limb ischemia, marked by intractable lower extremity ischemic rest pain and tissue loss, is a

165 f catheterizations with groin venous access, lower extremity itching, and deep venous thrombosis.

166 ite the therapeutic effect on both upper and lower extremities, its role in motor control and coordin

167 urgical foot interventions that might affect lower extremity joint alignment, structure and pain in r

168 Lower extremity joint replacement at a BPCI-participatin

169 care fee-for-service beneficiaries who had a lower extremity joint replacement at a BPCI-participatin

170 There were 29441 lower extremity joint replacement episodes in the baseli

171 tiative, Medicare payments declined more for lower extremity joint replacement episodes provided in B

172 m 5.8% (95% CI, 5.8%-5.9%) for patients with lower extremity joint replacement to 18.8% (95% CI, 18.8

173 e included stroke, lower extremity fracture, lower extremity joint replacement, debility, neurologic

174 g 12,379 patients (41% female) who underwent lower extremity (LE)-PVI from 2004 to 2009 at 16 hospita

175 and overlapping representations of upper and lower extremity movement kinematics in subthalamic units

176 ter trial involving 53 patients referred for lower extremity MR angiography for suspected or known ch

177 A full lower extremity MRI and a detailed knee MRI were taken.

178 escent dye injected into fast or slow twitch lower extremity muscle with slice recordings from the fl

179 udy achieved highly reproducible measures of lower extremity muscles across centers and from day to d

180 ischemia-related pathophysiologic changes in lower extremity muscles and peripheral nerves of people

181 arteries and microvascular landmarks in the lower extremities of 10 healthy volunteers.

182 connectivity of somatosensory gating in the lower extremities of healthy human participants.

183 This study examined VPT at the upper and lower extremities of subjects with hip OA compared with

184 extremity endovascular revascularization and lower extremity open surgery.

185 ntration relationships in both the upper and lower extremities--optimal strategies are not yet clear.

186 role of biomechanics in the pathogenesis of lower-extremity osteoarthritis and recent advances in bi

187 Progression of lower-extremity osteoarthritis is mediated by aberrant b

188 ly poorer vibration perception in the distal lower extremities (P = .008, adjusting for age, height,

189 Men and women with lower extremity PAD have lower calf muscle density and r

190 We recruited outpatients with lower extremity PAD identified from medical records as c

191 l revascularization strategy for symptomatic lower extremity PAD is not established.

192 l revascularization strategy for symptomatic lower extremity PAD is not established.

193 nts were identified as probable smokers with lower extremity PAD; 232 met study eligibility requireme

194 reased the adjusted hazard ratio of ischemic lower-extremity PAD (1.54 [95% CI, 1.14-2.10]) (p = 0.00

195 associated with faster functional decline in lower-extremity PAD are understudied.

196 During the follow-up period, ischemic lower-extremity PAD developed in 24.4% of hemodialysis p

197 e associated with the occurrence of ischemic lower-extremity PAD in hemodialysis patients.

198 er in hemodialysis patients in whom ischemic lower-extremity PAD occurred (3.03% [IQR, 2.36-4.54], n

199 se patients until the occurrence of ischemic lower-extremity PAD.

200 utcomes were ODI change at 1 year, change in lower extremity pain (measured on a 0-10 scale; higher s

201 with pain-free participants, those reporting lower extremity pain had greater odds of having poor phy

202 with pain-free participants, those reporting lower extremity pain had significantly lower Impact of W

203 Among patients with lower extremity pain, the likelihood of the clinical syn

204 on diagnosis in older adults presenting with lower extremity pain.

205 rtic dissection who presented with bilateral lower extremity paraplegia and development of rhabdomyol

206 Measures of lower extremity performance were at least 30% lower than

207 he ankle brachial index, greater declines in lower extremity performance, and higher rates of cardiov

208 ity of monitoring serial regional changes in lower extremity perfusion has not been examined.

209 Men and women with lower extremity peripheral arterial disease (PAD) have h

210 We hypothesized that women with lower extremity peripheral arterial disease (PAD) would

211 stics with functional decline in people with lower extremity peripheral arterial disease are unknown.

212 for improving walking ability in people with lower extremity peripheral artery disease (PAD) are uncl

213 Lower extremity peripheral artery disease (PAD) is frequ

214 Among persons with lower extremity peripheral artery disease (PAD), we dete

215 ase (CVD) mortality among men and women with lower extremity peripheral artery disease (PAD).

216 Lower extremity peripheral artery disease is the third l

217 mined 23,934 consecutive patients undergoing lower extremity peripheral vascular interventions betwee

218 rates of functional decline in persons with lower-extremity peripheral arterial disease.

219 associated with amputation in patients with lower-extremity peripheral artery disease (LE PAD) durin

220 nfrarenal aortic diameter is associated with lower-extremity peripheral artery disease (LE-PAD).

221 Most arterial studies investigated lower-extremity peripheral artery disease and acute stro

222 chronic kidney disease is a risk factor for lower-extremity peripheral artery disease.

223 heart disease), brain (ischemic stroke), or lower extremities (peripheral vascular disease).

224 Participants' lower-extremity physical ability was assessed every 3 ye

225 significantly improved exercise capacity and lower extremity power.

226 opment (MCD) or spinal muscular atrophy with lower extremity predominance (SMALED), as well as three

227 mouse model for spinal muscular atrophy with lower extremity predominance and a combination of live-c

228 ic dynein cause spinal muscular atrophy with lower extremity predominance, Charcot-Marie-Tooth diseas

229 e features of BICD2 spinal muscular atrophy, lower extremity predominant are consistent with a pathol

230 BICD2 spinal muscular atrophy, lower extremity predominant most commonly presents with

231 Spinal muscular atrophy, lower extremity-predominant, is characterized by lower l

232 history of peripheral artery disease of the lower extremities (previous peripheral bypass surgery or

233 on costs per year attributed to misdiagnosed lower extremity pseudocellulitis.

234 ear on the musculoskeletal kinematics of the lower extremities remain poorly understood.

235 transesophageal cardiovascular Doppler, and lower extremity repositioning should be performed as soo

236 Lower extremity resistance training improved functional

237 ssigned to supervised treadmill exercise, to lower extremity resistance training, or to a control gro

238 is an atherosclerotic disease affecting the lower extremities, resulting in skeletal muscle ischemia

239 57%) patients enrolled based on the previous lower extremity revascularization criterion.

240 ular intervention after endovascular or open lower extremity revascularization for propensity-score m

241 ular intervention after endovascular or open lower extremity revascularization for propensity-score m

242 Although lower extremity revascularization is effective in preven

243 d patient characteristics accounted for 12% (lower extremity revascularization) to 57% (esophagectomy

244 e also associated with poorer outcomes after lower extremity revascularization, including graft reste

245 ated with improved 1-year limb salvage after lower extremity revascularization.

246 l ankle-brachial index </=0.80 or a previous lower extremity revascularization.

247 nel recommends that the Fugl-Meyer Upper and Lower Extremity scales be used as primary outcomes in in

248 ons with chronic stroke Fugl-Meyer Upper and Lower Extremity scales showing the strongest evidence fo

249 Those are the Fugl-Meyer Upper Extremity and Lower Extremity scales, Wolf Motor Function Test, Action

250 evere bilateral optic disc edema with distal lower-extremity sensory and motor deficits and electrodi

251 patients with stroke, but more patients had lower-extremity skin damage (RR, 4.02 [CI, 2.34 to 6.91]

252 ty of the patients admitted (66.6%) suffered lower extremity soft tissue and bony injuries, and 31 ha

253 ited neurological disorders characterized by lower extremity spastic weakness.

254 ited neurological disorders characterized by lower extremity spastic weakness.

255 gical disorders characterized principally by lower extremity spasticity and weakness due to a length-

256 ited neurological disorders characterized by lower extremity spasticity and weakness.

257 1-71) with the unifying feature of prominent lower extremity spasticity, owing to a length-dependent

258 normal neurologic examination with preserved lower extremity strength and sphincter tone.

259 wer calf muscle density and poorer upper and lower extremity strength are associated with higher mort

260 D have lower calf muscle density and reduced lower extremity strength compared with individuals witho

261 muscle endurance), isometric knee extension (lower extremity strength), unipedal stance time (static

262 thy rats, as evident from a 6.7% increase in lower extremity strength, measured by grip test.

263 age +/- SD, 13.4 +/- 2.4 years; 50% male) on lower-extremity strength testing, the timed up-and-go (T

264 roups improved significantly with respect to lower-extremity strength, aerobic capacity, pain, stiffn

265 What treatments for lower extremity superficial thrombophlebitis are associa

266 resting systolic blood pressure and upper to lower extremity systolic blood pressure gradient (ULG).

267 evealed no evidence of pulmonary embolism or lower extremity thrombus.

268 CT venography may be limited to the lower extremities, thus reducing radiation dose.

269 involving upper arm training in concert with lower extremity training can enhance locomotor recovery

270 en Bypass vs Angioplasty and Stenting of the Lower Extremity Trial (ROBUST) is the first prospective

271 her 50s with cryoglobulinemia and bilateral lower extremity ulcers of 1 year's duration developed ac

272 erstersia gyiorum, in a patient with chronic lower-extremity ulcers, and we review the literature on

273 assic SMS (n = 5, involving the low back and lower extremities), variant SMS (n = 2, limited to 1 lim

274 terectomy (28.8%), arthroplasty (18.8%), and lower extremity vascular bypass (36.4%).

275 nged from 3.8% for hysterectomy to 14.9% for lower extremity vascular bypass.

276 nee arthroplasty, ventral hernia repair, and lower extremity vascular bypass.

277 For each patient, we studied the use of lower extremity vascular procedures (open surgery or end

278 nded randomized study of patients undergoing lower extremity vascular procedures from 2011 to 2014.

279 neficiaries 65 and older who underwent major lower-extremity vascular procedures.

280 nical features and outcomes of patients with lower extremity vasculitis are explored in this review.

281 ndomized trial database, which included 1404 lower extremity vein graft operations performed exclusiv

282 In addition to deep lower extremity veins, superficial and pelvic veins are

283 ndividual burden caused by acute and chronic lower extremity venous disease is considerable.

284 or colorectal surgery underwent preoperative lower extremity venous duplex (LEVD) immediately before

285 Of 38,426 lower extremity venous duplex studies, 406 patients with

286 All patients underwent lower extremity venous duplex ultrasonography prior to h

287 From 14056 lower-extremity venous duplex studies, we identified 697

288 wounds, we analyzed debridement samples from lower-extremity venous insufficiency ulcers using the fo

289 At examination, strength in both lower extremities was slightly reduced, sensation and re

290 Lower extremity weakness predominated (46 [73%]).

291 ed about new or worsening back or neck pain, lower extremity weakness, or radiculopathy symptoms, 35

292 with 1 week of low back pain and progressive lower extremity weakness.

293 A brief 4-item scale encompassing lower-extremity weakness, cognitive impairment, anemia,

294 mphedema and lymph vessel transplants of the lower extremities were examined with 3.0-T fat-saturated

295 ables proton and phosphorus MRI of the human lower extremities with high spatial and temporal resolut

296 ppression was induced by irradiation of both lower extremities with shielding of the abdomen.

297 Radiotracer imaging of the lower extremities with techniques such as PET and SPECT

298 Seventy-four of these underwent lower extremity wound closure.

299 Treating posttraumatic lower extremity wounds can be challenging, especially in

300 Lower-extremity wounds are a major complication of diabe